DiscoverAUAUniversityAUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

Update: 2025-07-09
Share

Description

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems 

CME Available: https://auau.auanet.org/node/43047

At the conclusion of this activity, participants will be able to:
1. Implement current practice guidelines and explain methods and resources to improve transurethral resection of a bladder tumor (TURBT) skills.
2. Identify the best intravesical agent and duration of therapy for low-, intermediate-, and high-risk NMIBC and what to do during a BCG shortage.
3. Identify methods to treat significant toxicities from various intravesical therapies.
4. Define high-risk scenarios that necessitate cystectomy and options for BCG-unresponsive disease.
5. Identify the scientific rationale for investigating immune oncology agents for BCG-unresponsive disease and become familiar with current clinical trial designs.

ACKNOWLEDGEMENTS:
This educational activity is supported by an independent educational grants from:
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

American Urological Association